Discover how our customers leverage Genedata Selector® to accelerate and optimize advanced therapy development. Learn about our wide range of applications that ensure collaborative, streamlined, and regulatory compliant NGS-based processes.
Cell line development and cell culture optimization face a new era with the introduction of knowledge-driven genomics based on new technologies such as NGS and omics-based approaches.
The intelligent organization of large data volume is central to successful research and development of new crop protection products.
Our customers now have available a computational platform that supports our market-leading TLA technology and enables them to significantly increase the number of clones analyzed, thereby increasing the efficiency of their quality control and cell line development workflow.
To optimally handle the complex data, we need a centralized genome knowledge management and analysis solution that addresses the interdisciplinary challenges in the next-generation biotechnology innovations.
I like to compare Genedata's work with the structured organization of a library in which you can easily and quickly find the book you are looking for.
With Genedata Selector we can integrate a wide range of complex R&D-relevant data and make the data easily accessible within our globally distributed R&D organization.
Genedata Selector was our obvious choice.
Our many years of experience in working together so far have been very positive.
Cell Line Characterization 2.0:
Implementation of Sequence Variant Analysis via RNA-seq and Future Perspectives
Benjamin Lindner
Senior Data Scientist, Boehringer Ingelheim
A Newly Identified Small RNA Regulates NGNA Sialylation in CHO Cells
Simon Fischer
Senior Principal Scientist & Head of Cell Biology - Cell Line Development, Boehringer Ingelheim
Localization and Structural Characterization of Random Transgene Integration of CHO Manufacturing Clones Using Next-Generation Sequencing
Benjamin Lindner
Senior Data Scientist, Boehringer Ingelheim
